Based on the reported efficacy of SMILE (Yamaguchi, Cancer Sci, 2008), in 2009, we adopted a modified (m)SMILE (dexamethasone, methotrexate, ifosfamide, peg‐asparaginase, etoposide) regimen given every 3 weeks, followed by radiotherapy (RT) as our standard approach. Main differences from the ...